Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia. Svenningsson P. Biol Psychiatry 2026;100:127-128.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Svenningsson P. Ulotaront (SEP363856) Reduces Dopamine Release and Synthesis Capacity in Mice and Patients With Schizophrenia. Biol Psychiatry 2026;100:127-128.
PMID: 42342329